Clinical trial
Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia…
NCT00351273 · University of South Florida, Other · Completed
Key facts
| NCT number | NCT00351273 |
|---|---|
| Title | Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria |
| Official title | Phase 3 Trial to Assess the Efficacy of Long-term (6 Months) Combination Antibiotics as a Treatment for Chlamydia-induced Reactive Arthritis |
| Lead sponsor | University of South Florida, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arthritis, Reactive, Reiter Disease |
| Intervention type | Drug |
| Interventions | Doxycycline and Rifampin, Azithromycin and Rifampin, Placebo |
| Enrollment | 42 |
| Start date | May 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jul 12, 2006 |
| Last update posted | Nov 13, 2018 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: